Abstract

Mucosal surfaces are exposed to environmental substances and represent a major portal of entry for microorganisms. The innate immune system is responsible for early defense against infections and it is believed that the interferons (IFNs) constitute the first line of defense against viruses. Here we identify an innate antiviral pathway that works at epithelial surfaces before the IFNs. The pathway is activated independently of known innate sensors of viral infections through a mechanism dependent on viral O-linked glycans, which induce CXCR3 chemokines and stimulate antiviral activity in a manner dependent on neutrophils. This study therefore identifies a previously unknown layer of antiviral defense that exerts its action on epithelial surfaces before the classical IFN response is operative.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

References

  1. 1.

    Antiviral immune responses in the genital tract: clues for vaccines. Nat. Rev. Immunol. 10, 699–711 (2010).

  2. 2.

    , & Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev. Vaccines 7, 1435–1445 (2008).

  3. 3.

    Recognition of microorganisms and activation of the immune response. Nature 449, 819–826 (2007).

  4. 4.

    & Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637–650 (2011).

  5. 5.

    Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).

  6. 6.

    , , , & Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513–520 (2003).

  7. 7.

    et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006).

  8. 8.

    , , , & Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202, 1333–1339 (2005).

  9. 9.

    et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235–249 (2008).

  10. 10.

    , & Genital herpes. Lancet 370, 2127–2137 (2007).

  11. 11.

    et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101, 1315–1320 (2004).

  12. 12.

    et al. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181, 8604–8612 (2008).

  13. 13.

    et al. TLR3-deficiency renders astrocytes permissive to HSV infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122, 1368–1376 (2012).

  14. 14.

    et al. Innate recognition of HSV in human primary macrophages is mediated via the MDA5/MAVS pathway and MDA5/MAVS/Pol III independent pathways. J. Virol. 84, 11350–11358 (2010).

  15. 15.

    , & STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).

  16. 16.

    et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390–1394 (2013).

  17. 17.

    , , & Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11, 143–154 (2011).

  18. 18.

    et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773 (2013).

  19. 19.

    et al. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663–672 (1999).

  20. 20.

    et al. Interferon-λ renders epithelial cells of respiratory and gastrointestinal tract resistant to viral infections. J. Virol. 84, 5670–5677 (2010).

  21. 21.

    et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective TH1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153–162 (2003).

  22. 22.

    & CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207–215 (2011).

  23. 23.

    et al. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression. FASEB J. 27, 2584–2599 (2013).

  24. 24.

    et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. USA 111, E4066–E4075 (2014).

  25. 25.

    et al. A strategy for O-glycoproteomics of enveloped viruses–the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog. 11, e1004784 (2015).

  26. 26.

    , , & Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265–278 (2011).

  27. 27.

    et al. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect. Immun. 77, 2465–2473 (2009).

  28. 28.

    , , , & Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect. Immun. 79, 4029–4041 (2011).

  29. 29.

    , & Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect. Immun. 81, 2070–2075 (2013).

  30. 30.

    Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73, 6380–6386 (1999).

  31. 31.

    et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169–180 (2013).

  32. 32.

    , & Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor-κB. J. Biol. Chem. 272, 14899–14907 (1997).

  33. 33.

    & The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154, 5235–5244 (1995).

  34. 34.

    & Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45–60 (2004).

  35. 35.

    & Plant immunity: towards an integrated view of plant-pathogen interactions. Nat. Rev. Genet. 11, 539–548 (2010).

  36. 36.

    & in Mixed Effects Models in S and S-PLUS 273–301 (Springer, 2000).

Download references

Acknowledgements

We thank K.S. Petersen and I.M. Poulsen for technical assistance and the AU FACS Core facility for technical help. Supported by The Danish Medical Research Council (12-124330 to S.R.P.; 1331-00133B to H.H.W.), the Novo Nordisk Foundation (S.R.P.), the Lundbeck Foundation (R34-3855 to S.R.P.), Aarhus University Research Foundation (S.R.P.), the EU FP7 Mobilex program (1333-00090A to M.K.T.), the US National Institutes of Health (AI065309 to B.C.H.), Faculty of Health Sciences, AU (M.B.I.), the Danish National Research Foundation (DNRF107 to H.H.W.), the Excellence Programme for Interdisciplinary Research (CDO2016 to H.H.W.), the German Research Foundation (DFG, SFB 1054 to J.R.) and the European Research Council (FP7, grant agreement 322865 to J.R.).

Author information

Author notes

    • Line S Reinert
    •  & Martin K Thomsen

    These authors contributed equally to this work.

    • Christian K Holm
    •  & Søren R Paludan

    These authors jointly directed this work.

Affiliations

  1. Department of Biomedicine, University of Aarhus, Aarhus, Denmark.

    • Marie B Iversen
    • , Line S Reinert
    • , Martin K Thomsen
    • , Ramya Nandakumar
    • , Thaneas Prabakaran
    • , Sine K Kratholm
    • , Steen V Petersen
    • , Sebastian Frische
    • , Christian K Holm
    •  & Søren R Paludan
  2. Aarhus Research Center for Innate Immunology, University of Aarhus, Aarhus, Denmark.

    • Marie B Iversen
    • , Line S Reinert
    • , Martin K Thomsen
    • , Ramya Nandakumar
    • , Thaneas Prabakaran
    • , Sine K Kratholm
    • , Christian K Holm
    •  & Søren R Paludan
  3. Department of Cellular and Molecular Medicine, Centre for Glycomics, University of Copenhagen, Copenhagen, Denmark.

    • Ieva Bagdonaite
    • , Sergey Y Vakhrushev
    •  & Hans H Wandall
  4. Department of Pediatrics and Microbiology, Albert Einstein College of Medicine, New York, USA.

    • Natalia Cheshenko
    •  & Betsy C Herold
  5. Department of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.

    • Malgosha Krzyzowska
  6. Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

    • Fernando Ruiz-Perez
  7. Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.

    • Stanislas Goriely
  8. Department of Biostatistics, University of Aarhus, Aarhus, Denmark.

    • Bo Martin Bibby
  9. Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden.

    • Kristina Eriksson
  10. Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

    • Jürgen Ruland
  11. Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

    • Allan R Thomsen

Authors

  1. Search for Marie B Iversen in:

  2. Search for Line S Reinert in:

  3. Search for Martin K Thomsen in:

  4. Search for Ieva Bagdonaite in:

  5. Search for Ramya Nandakumar in:

  6. Search for Natalia Cheshenko in:

  7. Search for Thaneas Prabakaran in:

  8. Search for Sergey Y Vakhrushev in:

  9. Search for Malgosha Krzyzowska in:

  10. Search for Sine K Kratholm in:

  11. Search for Fernando Ruiz-Perez in:

  12. Search for Steen V Petersen in:

  13. Search for Stanislas Goriely in:

  14. Search for Bo Martin Bibby in:

  15. Search for Kristina Eriksson in:

  16. Search for Jürgen Ruland in:

  17. Search for Allan R Thomsen in:

  18. Search for Betsy C Herold in:

  19. Search for Hans H Wandall in:

  20. Search for Sebastian Frische in:

  21. Search for Christian K Holm in:

  22. Search for Søren R Paludan in:

Contributions

M.B.I., C.K.H. and S.R.P. conceived of the study; M.B.I., L.S.R., M.K.T., I.B., R.N., N.C., T.P., S.Y.V., M.K. and S.K.K. performed experiments; M.B.I., B.M.B., H.H.W., S.F., C.K.H. and S.R.P. analyzed data; F.R.-P., S.G., K.E., J.R., A.R.T., B.C.H., S.V.P. and H.H.W. provided reagents and intellectual guidance; and M.B.I. and S.R.P. wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Søren R Paludan.

Integrated supplementary information

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–8 and Supplementary Table 2

Excel files

  1. 1.

    Supplementary Table 1

    Supplementary information on mass spectrometry analysis of HSV-2 O-glycoproteome

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ni.3319

Further reading